ANCA-Associated Vasculitis Associated With Cardiovascular Events
Researchers studied the association between ANCA-associated vasculitis and adverse cardiovascular outcomes.
All articles by Emily Pond
Dapagliflozin Plus Verinurad and Febuxostat Reduces Serum Uric Acid Without Affecting Kidney Function
Researchers assessed the effect of adding dapagliflozin to verinurad and febuxostat on serum uric acid levels in patients with hyperuricemia.
Changes in Ultrasonography Features of Gout May Predict Flares After Prophylaxis Cessation
Researchers determined the effect of changes in ultrasonography features of monosodium urate crystal deposition on gouty flares after stopping prophylaxis.
Pegloticase in Combination With Methotrexate Improves Therapeutic Response in Uncontrolled Gout
Researchers examined the efficacy and safety of pegloticase in combination with methotrexate in patients with uncontrolled gout.
Urate-Lowering Therapy May Reduce Type 2 Diabetes Risk in Patients With Gout
Researchers investigated the association between gout, urate-lowering therapy use, and the risk of developing type 2 diabetes.
Guideline-Concordant Gout Therapy Associated With Improved Arterial Function, Reduced Inflammation
Researchers assessed whether initiating guideline-concordant gout therapy improved arterial function and reduced inflammation.
Azathioprine May Increase Pegloticase Responsiveness in Chronic Refractory Gout
Researchers determined the effect of azathioprine on the frequency of chronic refractory gout among patients who had persistent urate lowering from pegloticase therapy.
Allopurinol Not Associated With Increased All-Cause Mortality in Gout
Researchers evaluated the association between allopurinol use and mortality in patients with gout.
Serum Urate Does Not Have a Causal Effect on Gout Comorbidity Risk, According to Mendelian Randomization Studies
Researchers reviewed the causal relationships between gout, hyperuricemia, and associated comorbidities.
OMERACT Structural Gout Lesions Sensitive to Change During Urate-Lowering Therapy
The goal of this 6-month prospective observational study was to assess sensitivity to change of ultrasound structural gout lesions, as defined by the OMERACT ultrasound group, among patients with gout undergoing urate-lowering therapy.
- Loading...
Loading...
Next post in Hyperuricemia
Loading... 
Loading...